Xoma presents recombinant variant of rBPI21 with potent antiinfective activity Oct. 2, 1998 No Comments
Glaxo Wellcome's MMP inhibitor shows potential in treating sepsis in early clinical study Oct. 2, 1998 No Comments
Review of the preclinical activity of GAR-936, a glycylcycline antibiotic with clinical potential Oct. 2, 1998 No Comments
Results from human pharmacokinetic studies support once-daily dosing for MK-991 Oct. 1, 1998 No Comments
RSS